Trial Profile
Comparison between the administration of levosimendan or placebo in the preparation of critically ill patients who need heart surgery.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2015
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure; Myocardial infarction
- Focus Therapeutic Use
- 20 Jun 2011 New trial record